# OnCo record hb1801 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/hb1801/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "hb1801" ;
  schema:name "HB1801"@en ;
  schema:description "HB1801 is an experimental investigational agent whose form is not stated in the registry from Shanghai JMT-Bio in phase 3 trials for HER2-positive breast cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/hb1801/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=HB1801> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "not stated (registered as a drug or biological on ClinicalTrials.gov)" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:companies <https://onco.cc/companies/cspc/> ;
  onco:trials <https://onco.cc/trials/nct05838066/>, <https://onco.cc/trials/nct07441460/>, <https://onco.cc/trials/nct06747338/> .